Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells

J Clin Invest. 1990 Nov;86(5):1517-23. doi: 10.1172/JCI114870.

Abstract

Previous studies have demonstrated that 1-beta-D-arabinofuranosylcytosine (ara-C) induces terminal differentiation of human myeloid leukemia cells. Other studies have shown that the c-jun protooncogene is expressed during phorbol ester-induced myeloid differentiation. This work examines the effects of ara-C on c-jun gene expression in human KG-1 myeloid leukemia cells. The results demonstrate that c-jun transcripts are undetectable in uninduced KG-1 cells and that ara-C induces expression of this gene in a concentration- and time-dependent manner. Ara-C treatment was also associated with increases in c-jun transcripts in U-937, THP-1, and HL-60 myeloid leukemia cells. Furthermore, transcriptional run-on analysis has demonstrated that exposure to ara-C increases the rate of c-jun gene transcription. The results also demonstrate that while inhibition of protein synthesis superinduces c-jun mRNA levels in phorbol ester-treated KG-1 cells, cycloheximide had no effect on the induction of c-jun transcripts during ara-C treatment. Moreover, the half-life of c-jun transcripts in ara-C-treated KG-1 cells was 42 min. These findings suggest that the increase in c-jun mRNA observed during ara-C treatment is regulated by a transcriptional mechanism, and that c-jun may be involved in the induction of differentiation and regulation of gene expression by ara-C.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / genetics
  • Blotting, Northern
  • Cell Cycle
  • Cell Differentiation
  • Cytarabine / pharmacology*
  • DNA-Binding Proteins / genetics*
  • Dactinomycin / pharmacology
  • Gene Expression Regulation / drug effects*
  • Humans
  • Kinetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-jun
  • Proto-Oncogenes*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription Factors / genetics*
  • Transcription, Genetic / drug effects
  • Tumor Cells, Cultured

Substances

  • Actins
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-jun
  • Transcription Factors
  • Cytarabine
  • Dactinomycin
  • Tetradecanoylphorbol Acetate